Skip to main content
Earnings Labs
Surrozen, Inc. logo

Surrozen, Inc. (SRZN)

NASDAQ·Healthcare·Biotechnology

$30.13

+2.03%

Mkt Cap $220.81M

Analyst Ratings

Buy

3

Hold

0

Sell

0

Price Target (4 analysts)

$42.00

Range $40.00 – $44.00

Implied Upside

+39.4%

Consensus $42.00 vs current $30.13